James T. Bennett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
James T. Bennett has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Alexander D Veit
Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA
1 shared publicationAlexi M Runnels
New York Genome Center, New York, NY 10013, USA
1 shared publication- Amy E. Geddis
Center for Clinical and Translational Research, Seattle Children's Hospita, USAl; Division of Hematology-Oncology, Department of Pediatrics, Seattle Children's Hospital, USA
1 shared publication Andrew B Stergachis
Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA 98195, USA; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA
1 shared publicationAudrey Squire
Department of Pediatrics, Division of Genetic Medicine, University of Washington and Seattle Children's Hospital, Seattle, Washington
1 shared publicationAzeet Narayan
Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in Cell Genomics
- Vol. 6 (11) , 101390
Detecting low-allele-fraction mosaic mutations: A multi-institution benchmarking with cell-line mixtures
- 15 October 2026
- Published by Elsevier in Cell Genomics
- Vol. 6 (11) , 101390
Open AccessDetecting low-allele-fraction mosaic mutations: A multi-institution benchmarking with cell-line mixtures
- 15 November 2022
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 164, 111371
Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infants
- 15 November 2022
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 164, 111371
Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infants
- 8 December 2019
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 182 (3) , 543-547
A child with autism, behavioral issues, and dysmorphic features found to have a tandem duplication within CTNND2 by mate‐pair sequencing
We describe a 5‐year‐old male with developmental delay, behavioral problems, and dysmorphic features who was found by microarray to have a 93‐kb duplication of uncertain significance that fully encompasses the third exon of CTNND2 (delta catenin). Mate‐pair sequencing was used to determine that the duplication is tandem and is predicted to lead to CTNND2 haploinsufficiency. Haploinsufficiency for CTNND2 has been shown to result in developmental delay and intellectual disability, providing a unifying diagnosis for this patient. His features overlap those associated with the larger cri‐du‐chat deletion of this region, expanding the clinical phenotype of isolated CTNND2 variants. The use of mate‐pair sequencing to determine the orientation of the small duplication was essential to the diagnosis and avoided the use of exome sequencing, which would not have defined the arrangement of the duplication. This is only the second reported patient, to our knowledge, with a single exon duplication of CTNND2.
- 8 December 2019
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 182 (3) , 543-547
A child with autism, behavioral issues, and dysmorphic features found to have a tandem duplication within CTNND2 by mate‐pair sequencing
We describe a 5‐year‐old male with developmental delay, behavioral problems, and dysmorphic features who was found by microarray to have a 93‐kb duplication of uncertain significance that fully encompasses the third exon of CTNND2 (delta catenin). Mate‐pair sequencing was used to determine that the duplication is tandem and is predicted to lead to CTNND2 haploinsufficiency. Haploinsufficiency for CTNND2 has been shown to result in developmental delay and intellectual disability, providing a unifying diagnosis for this patient. His features overlap those associated with the larger cri‐du‐chat deletion of this region, expanding the clinical phenotype of isolated CTNND2 variants. The use of mate‐pair sequencing to determine the orientation of the small duplication was essential to the diagnosis and avoided the use of exome sequencing, which would not have defined the arrangement of the duplication. This is only the second reported patient, to our knowledge, with a single exon duplication of CTNND2.